Eli Lilly and Company (LLY)

147.44
NYSE
Prev Close 144.75
Day Low/High 145.36 / 147.92
52 Wk Low/High 115.92 / 170.75
Exchange NYSE
Shares Outstanding 956.58B
Market Cap 138.47B
P/E Ratio 23.73
Div & Yield N.A. (N.A)

Latest News

Nordstrom Is Not Finished Getting Dressed Up

Nordstrom Is Not Finished Getting Dressed Up

These calls are way too cheap.

Eli Lilly: Back From the Depths

Eli Lilly: Back From the Depths

I am flat LLY for now. Let's see how the shares behave around the technicals. Then we'll make an equity decision.

Reviewing the Markets, Spreading Covid-19, Vaccine Politics, My Boeing Plan

Reviewing the Markets, Spreading Covid-19, Vaccine Politics, My Boeing Plan

Just how many markets are there? We used to say 'the market' was up or down by so many points. No more.

Jim Cramer: Health Care Stocks, the Election and the Perfect Setup

Jim Cramer: Health Care Stocks, the Election and the Perfect Setup

Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

The 'work from home' or 'economic lockdown' trade is close to being back on.

Red Monday, Virus Rattles Market, Political Picture, Aerospace & Defense Stocks

Red Monday, Virus Rattles Market, Political Picture, Aerospace & Defense Stocks

This is a major earnings week, electoral risk is real, the virus is already slowing velocity, and the cavalry (fiscal policy) is not coming. Sometimes, circling the wagons is not the worst idea.

The Market's Week That Was, Upcoming Elections, the Economy, Stimulus

The Market's Week That Was, Upcoming Elections, the Economy, Stimulus

Portfolio managers are starting to see a very strong 2021 for markets and the economy regardless of electoral results.

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

The Market Needs Some Rest but There Are Many Positives at Work

The Market Needs Some Rest but There Are Many Positives at Work

Market participants ignore negative news and continue to pursue individual stocks into earnings season.

We Fell, but It Could Have Been Worse

We Fell, but It Could Have Been Worse

Given the news of the day, you'd think we would have had a violent pullback -- instead here's what we got.

Jim Cramer: Let the Market's Patterns Guide You

Jim Cramer: Let the Market's Patterns Guide You

Some patterns reveal themselves easily, and you can spot them ahead of the computer programs. Here are examples of them, and how to act.

Jim Cramer: Here's How We're Going to Beat Covid-19

Jim Cramer: Here's How We're Going to Beat Covid-19

Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.

Where Does This Broad Rally Go? Q3 Earnings Begin, Amazon's Prime Day, Apple 5G

Where Does This Broad Rally Go? Q3 Earnings Begin, Amazon's Prime Day, Apple 5G

What stocks do from here will, beyond electoral risk and potential stimulus, rely upon fourth quarter guidance.

Should You Invest in Regeneron, Lilly, or Gilead?

Should You Invest in Regeneron, Lilly, or Gilead?

Invest either because of their profitable portfolio, their impressive pipeline, or their technical set-up.

Is Psilocybin the New CBD?

Is Psilocybin the New CBD?

As psychedelic medicines begin to become decriminalized, psilocybin seems to be leading the way in this category.

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.

Eli Lilly Could Rally After Passing the Test

Eli Lilly Could Rally After Passing the Test

Successful tests of a rising 200-day moving average line can be great entry points for longs.

Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff

Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff

Electoral risk remains the monster under the bed, and it only grows as our legislators intentionally choose the blame game over honest cooperation.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Here's How I'm Trading XBiotech

Here's How I'm Trading XBiotech

Do these shares get back to the 2020 highs that were reached back in January?

Jim Cramer: Betting Against Science Is a Mug's Game

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Charting the Stocks of 3 Covid Treatment Companies

Charting the Stocks of 3 Covid Treatment Companies

Let's take a close look at Gilead Sciences, Regeneron and Eli Lilly.

7 Drug Stocks With the Right Medicine for Investors

7 Drug Stocks With the Right Medicine for Investors

These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.

Eli Lilly Shoots Up Following Drug Study

Eli Lilly Shoots Up Following Drug Study

Potential for a new blockbuster breast cancer treatment is eyed as possible game changer, so let's see the charts and indicators for a new target.

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.

A Triangle Formation on Drug Maker Eli Lilly Is Ready for an Upside Breakout

A Triangle Formation on Drug Maker Eli Lilly Is Ready for an Upside Breakout

The question is whether you want to buy before the breakout or after the breakout?